Bio-Techne (TECH) Misses Q2 EPS by 4c

Bio-Techne (NASDAQ: TECH) reported Q2 EPS of $0.81, $0.04 worse than the analyst estimate of $0.85. Revenue for the quarter came in at $131.8 million versus the consensus estimate of $134.5 million.

For earnings history and earnings-related data on Bio-Techne (TECH) click here.

You May Also Be Interested In

• DocGo (DCGO) Misses Q2 EPS by 6c; Offers Guidance
• The LGL Group (LGL) Misses Q2 EPS by 8c
• Fabrinet (FN) Tops Q4 EPS by 29c, Beats on Revenue; Offers Guidance